VKTX

Viking Therapeutics
$34.87
+$0.08 (+0.23%)Jul 27, 2026
2.9FairMoatMint rating

MoatMint rates Viking Therapeutics (VKTX) 2.9 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.8 out of 10.

Key metrics

The numbers that frame VKTX today
Market cap
$4.05B
P/E (TTM)
-8.6
EV / FCF
-11.5
ROIC
-84.6%
Div yield
0%
Debt / equity
0.0
52wk Low
$22.96
52wk High
$43.15

VKTX stock rating

How VKTX scores on quality, value, growth, momentum and financial health
2.9out of 10
Fair overallFair business, expensive priceTop 71% of ~5,000 US stocks
QualityFair2.8/10
GrowthFair2.6/10
MomentumGood7.0/10
ValueFair2.3/10
Financial HealthNeutral4.2/10

Growth

Revenue and earnings trend for VKTX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about VKTX
Is Viking Therapeutics a good buy?
Hold. Viking Therapeutics has strong momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Viking Therapeutics is selling at a very high price.
What is the market capitalization of VKTX?
Viking Therapeutics's market capitalization is $4.05B.
What is the P/E ratio for VKTX stock?
Viking Therapeutics's current P/E ratio is -8.6.
What is the 52-week high for VKTX stock?
The 52-week high for Viking Therapeutics is $43.15. The current close of $34.87 is 19.2% below that high.
What is the 52-week low for VKTX stock?
The 52-week low for Viking Therapeutics is $22.96. The current close of $34.87 is 51.9% above that low.
Does VKTX stock pay dividends?
Viking Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VKTX?
Viking Therapeutics's Debt / Equity ratio is 0.